From Design to Delivery: A Translational Framework for Non-Viral Gene Editing

The rapid expansion of genomic medicine has intensified the need for scalable, regulatory-aligned and high-fidelity gene editing workflows that can efficiently transition from discovery to clinical evaluation. Aldevron and Integrated DNA Technologies (IDT) are at the forefront of a non-viral gene editing framework designed to support programs across in vivo and ex vivo therapeutic modalities. Emphasis is placed on editing specificity, off-target assessment and manufacturability to support IND-enabling studies. In this webinar, you will be able to:

1. Map a non-viral CRISPR-mediated gene editing workflow to support in vivo and ex vivo genomic medicine applications.
2. Understand manufacturability and quality constraints needed to ensure consistency, traceability and IND readiness for complex editing components. 
3. Integrate off target safety profiling, analytical services and regulatory expectations into an evidence package that supports non viral gene editing IND filings.